Ozempic-maker Novo Nordisk turned to the actors from Apple’s 2000s “Get a Mac” ads to differentiate its GLP-1 medication amid a rising sea of competitors.
On January 20, the Danish pharmaceutical company announced its “There’s Only One Ozempic” campaign starring Justin Long and John Hodgman. The actors are reprising their roles from Apple’s Mac vs. PC ads playing the personifications of a name brand and the alternative—but now for weight-loss drugs.
Long personified Mac in the original Apple campaign by dressing in a more youthful, casual way than Hodgman, who personified a stuffy, dorky PC by wearing glasses and a suit and tie with a closely cropped haircut. (Think Steve Jobs versus Bill Gates.) In the Apple ads, Mac was always portrayed by Long as more cool and capable.
In the new Ozempic ad, Long personifies Ozempic, facing off in a mock game show against Hodgman, who plays all of Ozempic’s competitors wrapped up in one dull brown T-shirt. (His hardworking name is “Other GLP-1s for Type 2 Diabetes.”) Hodgman’s character gets the game show’s single question right after the host asks which GLP-1 is approved by the Food and Drug Administration to lower the risk of worsening chronic kidney disease. The answer is, of course, “Ozempic,” which ultimately makes his win bittersweet.
The “Get a Mac” campaign was created by Apple’s ad agency TBWA\Media Arts Lab; 66 total spots aired from 2006 to 2009. In 2010, Adweek named it the best ad campaign of the 2000s for connecting technology to humanity. Now Novo Nordisk is hoping some of that magic can rub off.
The new campaign aims to reassert Ozempic’s brand equity in the public sphere as it faces business headwinds. It follows both layoffs and lower sales growth at the company, even as its U.S. competitor Eli Lilly is ascendent. The ad also drops shortly after Novo Nordisk’s other GLP-1, Wegovy, hit the market in pill form.
In such a competitive landscape, Novo Nordisk is working to make its brand name the standard. “There’s Only One Ozempic” plays up Ozempic’s unique selling proposition in a practical sense, as a solution to chronic kidney disease. But with a jingle based on the song “Magic” and a pair of actors remembered for selling computers, it’s also positioning its drug as the most desirable GLP-1.
